Press releases

Alcon gains exclusive ex-US rights for ocriplasmin, potential first pharmacological treatment for symptomatic vitreomacular adhesion

Alcon, the global leader in eye care and a division of Novartis, announced today that it has gained exclusive rights to commercialize ocriplasmin outside the United States for the treatment of symptomatic vitreomacular adhesion (VMA). If approved, it will (more)

euroPLX 48 Lisbon Schedules 4,000 Face-toFace Meetings

Partnering event productivity is measured by business negotiations per company, not by the total number of scheduled appointments. (more)

APR Applied Pharma Research ("APR") and Labtec GmbH ("Labtec") announce the European approval of Zolmitriptan Oral Dispersible Film (ODF)

APR and Labtec announce to have received on February 8th, 2012, the marketing authorization through a decentralized procedure (DCP) in 15 European countries of Zolmitriptan ODF, a film strip formulation containing 2.5mg and 5mg Zolmitriptan . It is their (more)

Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program

Innocoll Announces Successful End-of-Phase 2 Meeting with FDA for XaraColl® and Agreement of the Phase 3 Program (more)

Innocoll Enters CollaGUARD® Distribution Partnership with Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany

Innocoll Enters CollaGUARD® Distribution Partnership with Flynn Pharma Ltd in the UK and Inresa Arzneimittel GmbH in Germany (more)

APR Applied Pharma Research s.a., Labtec GmbH and Norgine BV Announce the Signature of an Exclusive Licensing Agreement under Which Norgine Will Market and Distribute Setofilm™

APR Applied Pharma Research s.a. (“APR”), Labtec GmbH (“Labtec”) and Norgine BV (“Norgine”) announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm™ Ondansetron Oral Dispersible Film (“ODF”), in E (more)

APR Applied Pharma Research s.a. , Labtec GmbH and Norgine announce the signature of an exclusive licensing agreement under which Norgine will market and distribute Setofilm(TM)

Norgine and APR, together with its joint venture partner Labtec, today announced that they have entered into an exclusive licensing agreement under which Norgine has acquired the commercialization rights in Europe and selected non-European countries in Mi (more)

The Most Important Business Platform for Many Life Science Companies

Returning customers make euroPLX the most often attended partnering conference. (more)

Innovaro Announces Successful Sale of the Waycool Portfolio of Patents by CUI Global, Inc.

Tampa, FL -- (Business Wire) – January 5, 2012 – Innovaro, Inc (NYSE Amex: INV), a leading IP licensing and innovation services company, is pleased to announce that its client CUI Global, Inc. (formerly Waytronx) has completed the sale of selected patents (more)

UAMS BioVentures company Myeloma Health, LLC continues to grow its diversified menu of cancer diagnostic signatures

Signal Genetics to launch second generation Myeloma product, MyPRS Plus (more)